Corcept Therapeutics Inc <CORT.O>: Canaccord Genuity Raises Target Price to $161 From $150
CORT•Related News
Adidas shares slide record 17% as profit miss taints sales upgrade
XLY•
Euro zone yields climb after Fed drives sell-off and oil prices rise
TLT•
Nasdaq trade halt continues <OST.O> reason not available at 03:58 AM
OST•
U.S. Research Roundup-Equinix, Meta, S&P Global
SPY•
Samsung sees chip shortage extending to 2028, touts long-term supply deals
SOXX•